Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vapendavir in Asthmatic Adults with HRV Infection
NCT02367313Phase 2Completed
- Sponsor
- Aviragen Therapeutics
- Start
- Feb 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of Vapendavir in human rhinovirus infection, sponsored by Aviragen Therapeutics. Started Feb 2015; status: completed.
02
Drugs
Vapendavir
03
Conditions
human rhinovirus infection
Beyond the preview
Go deeper on NCT02367313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02367313.